Related Experiment Video
Updated: Jun 24, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
p53 suppresses Src-induced podosome and rosette formation and cellular invasiveness through the upregulation of
Utpal K Mukhopadhyay1, Robert Eves, Lilly Jia
1Department of Biochemistry, Queen's University, Kingston, ON, Canada.
Abstract:
The tumor-suppressive role of p53 at the level of tumor initiation is well documented. It has also been shown previously that p53 acts against tumor progression/metastasis. However, its role in modulating cell migration and invasion leading to metastasis is poorly understood. In this study, using vascular smooth muscle cells and NIH 3T3 fibroblast cells, we have shown that p53 potently suppresses Src-induced podosome/rosette formation, extracellular matrix digestion, cell migration, and invasion. The overexpression of exogenous wild-type p53 or the activation of the endogenous p53 function suppresses, while the short hairpin RNA-mediated knockdown of p53 expression or the pageing of its function exacerbates, Src-induced migratory and invasive phenotypes. We have also found that p53 expression and function are downregulated in cells stably transformed with constitutively active Src that exhibit aggressive invasive properties. Lastly, p53 upregulates the expression of caldesmon, an actin-binding protein that has been shown to be an inhibitor of podosome/invadopodium formation. The ability of p53 to suppress Src phenotypes in transformed cells was largely abolished by knocking down caldesmon. This study reports a novel molecular mechanism (caldesmon), as well as a structural basis (podosomes/rosettes), to show how p53 can act as an anti-motility/invasion/metastasis agent.
Insights
The tumor suppressor p53 inhibits cancer cell migration and invasion by downregulating podosome formation. This study reveals p53
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The tumor suppressor p53's role in preventing tumor initiation is established.
- p53's function in inhibiting tumor progression and metastasis is known, but its specific mechanisms are unclear.
- The impact of p53 on cell migration and invasion, key steps in metastasis, requires further investigation.
Purpose of the Study:
- To investigate the role of p53 in suppressing Src-induced cell migration and invasion.
- To elucidate the molecular mechanisms by which p53 affects cell motility and extracellular matrix degradation.
- To identify novel pathways regulated by p53 that control cancer cell invasion and metastasis.
Main Methods:
- Utilized vascular smooth muscle cells and NIH 3T3 fibroblast cells.
- Manipulated p53 expression and function using overexpression and short hairpin RNA (shRNA) knockdown.
- Assessed podosome/rosette formation, extracellular matrix digestion, cell migration, and invasion assays.
- Analyzed p53 and caldesmon expression in Src-transformed cells.
Main Results:
- p53 overexpression or activation suppressed Src-induced podosome formation, ECM digestion, migration, and invasion.
- p53 knockdown or inactivation exacerbated these Src-driven phenotypes.
- Cells with constitutively active Src showed downregulated p53 expression and function, correlating with aggressive invasion.
- p53 upregulated caldesmon, an actin-binding protein inhibiting podosome formation; caldesmon knockdown diminished p53's suppressive effects.
Conclusions:
- p53 acts as a potent suppressor of Src-induced cell migration, invasion, and extracellular matrix digestion.
- p53 exerts its anti-metastatic effects, in part, by upregulating caldesmon, which inhibits podosome formation.
- This study identifies a novel mechanism involving caldesmon and podosomes through which p53 functions as an anti-metastasis agent.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer Cell Migration through Invadopodia
DNA Damage can Stall the Cell Cycle